Geode Capital Management’s Aimei Health Technology Co AFJK Stock Holding History

Geode Capital Management’s Portfolio AFJK Stock Details AFJK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,452	Closed	-$413K	–	4514
2025 Q4	$413K	Buy	+6,452	New	+$141K	﹤0.01%	3663

Other funds holding AFJK

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management's AFJK Position: Q1 2026 in Review

Geode Capital Management sold out of Aimei Health Technology Co (AFJK) in Q1 2026, closing a stake of 6,452 shares — an estimated $413K sold.

Geode Capital Management first reported a position in AFJK in Q4 2025 and held it in 1 quarter. The position peaked at $413K in Q4 2025. 8 funds tracked by Wall St. Rank hold AFJK as of Q1 2026.

Geode Capital Management reported no remaining Aimei Health Technology Co position as of Q1 2026 after selling out during the quarter.
Geode Capital Management sold 6,452 Aimei Health Technology Co shares in Q1 2026, an estimated $413K.
Geode Capital Management first reported a position in Aimei Health Technology Co in Q4 2025 and held it in 1 quarter.
Geode Capital Management's Aimei Health Technology Co position peaked at $413K in Q4 2025.
8 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.